By blocking a neutrophil receptor that binds to endothelium (CD18) [23] or an adhesion molecule (L-selectin) [16] with an antibody, researchers hoped to prevent neutrophils from extravasating and causing reperfusion injury after hemorrhagic shock. Here, SELL is linked to Shock.